Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FPW7V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,688
Award facts
- Contract value 100% obligated
- $43,688.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $43,688.38 delivery order to AmerisourceBergen Drug Corp for Kesimpta 20 mg/0.4 ml pen injections. This is a firm fixed-price, competitively awarded contract with a completion date of December 31, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will perform the work. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical deliveries encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas. Kesimpta is a specialty pharmaceutical used in the treatment of multiple sclerosis, consistent with AmerisourceBergen's role as a provider of neurological treatments and other specialized medications to federal healthcare programs. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning companies like AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FPW7V?
SPE2DR26FPW7V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FPW7V worth?
The government has obligated $43,688 on SPE2DR26FPW7V.
Is contract SPE2DR26FPW7V an order under another contract?
Yes. SPE2DR26FPW7V is a delivery order under SPE2DR25D1034, an indefinite delivery contract.
Was contract SPE2DR26FPW7V competed?
The extent of competition for SPE2DR26FPW7V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award